Manufacturer withdraws treatment for sickle cell disease following concern over deaths Pfizer's withdrawal is based on data that suggest “an imbalance in vast-occlusive crises and fatal events which require further assessment”.…
The 20-year path to placing specialist pharmacists in all critical care units With the launch of a new advanced pharmacist curriculum for critical care, a leading pharmacist in the field outlines the specialism’s progress over two decades.…
Pharmacy First monthly payment threshold cut for a second time The monthly threshold to qualify for a £1,000 payment was due to be increased to 30 consultations in October 2024, but this has been reduced to 20 consultations.…
Changes to hub-and-spoke legislation will be delayed, government tells CPE Community Pharmacy England says it has been told by the Department for Health and Social Care that the changes will not happen from 1 January 2025 as planned.…
Prescribing dilemma: balancing risk and benefits of off-label migraine treatment in a child The second of a new series of articles exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…
